Clinical Trial Update: Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial evaluating the safety and immunogenicity of a cholera conjugate vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Cholera Conjugate Vaccine (Cholera conjugate vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera Vaccination Reaction | Phase 1 | Status: COMPLETED